SPARC and colorectal carcinoma: Two further potential biomarkers of interest in the pathogenesis and prognosis of CRC are Secreted Protein Acidic and Rich in Cysteine (SPARC) and forkhead box P3 (FOXP3) as they are also both highly expressed in malignant diseases and have been demonstrated to significantly correlate with disease outcome.